WHO Raises Warning Over Severe Lack of Weight-Loss Jabs
Fewer than one in 10 people who could benefit from GLP-1 drugs including Wegovy are able to get them, states the WHO as it publishes its inaugural guidance on the therapies.
With in excess of 1,000,000,000 individuals worldwide currently living with obesity, it is urging increased and just access to GLP-1 medication.
Per projections, over two billion could be living with obesity by 2030 unless action is taken.
"The new guidance affirms that excess weight is a lifelong illness that can be addressed with thorough and lifelong treatment," remarked the agency's head Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and supply-chain constraints are major barriers to widespread access to the injections that can aid individuals in losing significant weight, says the agency.
GLP-1 Therapy Supply Crisis
Despite the present best projected case, the production of these medications could only cover approximately 100 million people – under 10% of the global need, per the health organization.
The recommendation calls on countries and companies to expand availability, via measures including voluntary licensing.
The intellectual property rights on the active ingredient – the primary ingredient of a leading brand – is scheduled to end in a number of countries in 2026.
The Way Obesity Injections Function
The injections mimick a natural hormone to reduce digestion speed, suppress the appetite and boost the sense of being full so people reduce food intake.
People commonly begin shedding pounds within a few weeks of commencing the regular doses.
Research indicates users may put most of the weight back on a year later of stopping the drug, because their usual food cravings come back.
To be overweight or obese elevates your likelihood for developing diseases, like diabetes, cardiovascular issues, stroke, and certain cancers.
Excess weight concerns individuals in countries worldwide and was associated with 3.7 million deaths worldwide in 2024, according to the WHO.
